{"entity":{"type":"insider","cik":"0001656633","url":"/insider/0001656633","json_url":"/insider/0001656633.json","name":"CRYSTAL ROGER","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":13,"first":"2017-01-19","last":"2023-01-31","span_basis":"filed_date"},"name_variants":[{"name":"CRYSTAL ROGER","source":"filing","n_filings":13,"first_seen":"2017-01-19","last_seen":"2023-01-31"}],"transactions":[{"id":8382627,"accession":"0001385508-23-000034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-23-000034","line_url":"/filing/0001385508-23-000034#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1358.0,"shares_display":"1,358","price_per_share":20.26,"price_display":"20.26","price_state":"stated","total_value":27513.08,"total_display":"27,513.08","total_whole":"27,513","shares_owned_after":75339.0,"shares_owned_after_display":"75,339","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-27","filed_date":"2023-01-31","scope":"insider"},{"id":7980149,"accession":"0001385508-23-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-23-000018","line_url":"/filing/0001385508-23-000018#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1183.0,"shares_display":"1,183","price_per_share":20.2,"price_display":"20.20","price_state":"stated","total_value":23896.6,"total_display":"23,896.60","total_whole":"23,897","shares_owned_after":76697.0,"shares_owned_after_display":"76,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-09","scope":"insider"},{"id":8444468,"accession":"0001385508-23-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-23-000005","line_url":"/filing/0001385508-23-000005#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5029.0,"shares_display":"5,029","price_per_share":20.2,"price_display":"20.20","price_state":"stated","total_value":101585.8,"total_display":"101,585.80","total_whole":"101,586","shares_owned_after":77880.0,"shares_owned_after_display":"77,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-05","scope":"insider"},{"id":6338952,"accession":"0001385508-22-000109","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-22-000109","line_url":"/filing/0001385508-22-000109#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2246.0,"shares_display":"2,246","price_per_share":11.11,"price_display":"11.11","price_state":"stated","total_value":24953.06,"total_display":"24,953.06","total_whole":"24,953","shares_owned_after":82909.0,"shares_owned_after_display":"82,909","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-14","filed_date":"2022-07-15","scope":"insider"},{"id":6798282,"accession":"0001385508-22-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-22-000025","line_url":"/filing/0001385508-22-000025#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1995.0,"shares_display":"1,995","price_per_share":26.15,"price_display":"26.15","price_state":"stated","total_value":52169.25,"total_display":"52,169.25","total_whole":"52,169","shares_owned_after":78488.0,"shares_owned_after_display":"78,488","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-27","filed_date":"2022-01-27","scope":"insider"},{"id":6260174,"accession":"0001385508-22-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-22-000020","line_url":"/filing/0001385508-22-000020#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1058.0,"shares_display":"1,058","price_per_share":30.49,"price_display":"30.49","price_state":"stated","total_value":32258.42,"total_display":"32,258.42","total_whole":"32,258","shares_owned_after":80483.0,"shares_owned_after_display":"80,483","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-10","filed_date":"2022-01-12","scope":"insider"},{"id":5270353,"accession":"0001385508-21-000134","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-21-000134","line_url":"/filing/0001385508-21-000134#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock par value $0.001","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":23.44,"price_display":"23.44","price_state":"stated","total_value":2344.0,"total_display":"2,344.00","total_whole":"2,344","shares_owned_after":5100.0,"shares_owned_after_display":"5,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-16","filed_date":"2021-09-16","scope":"insider"},{"id":8401355,"accession":"0001385508-19-000039","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-19-000039","line_url":"/filing/0001385508-19-000039#line-3","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12772.0,"shares_display":"12,772","price_per_share":12.1,"price_display":"12.10","price_state":"stated","total_value":154541.2,"total_display":"154,541.20","total_whole":"154,541","shares_owned_after":8475.0,"shares_owned_after_display":"8,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-08","filed_date":"2019-04-08","scope":"insider"},{"id":8401353,"accession":"0001385508-19-000039","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-19-000039","line_url":"/filing/0001385508-19-000039#line-2","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16001.0,"shares_display":"16,001","price_per_share":11.98,"price_display":"11.98","price_state":"stated","total_value":191691.98,"total_display":"191,691.98","total_whole":"191,692","shares_owned_after":21247.0,"shares_owned_after_display":"21,247","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-05","filed_date":"2019-04-08","scope":"insider"},{"id":8528694,"accession":"0001385508-19-000037","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001385508-19-000037","line_url":"/filing/0001385508-19-000037#line-6","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16836.0,"shares_display":"16,836","price_per_share":11.93,"price_display":"11.93","price_state":"stated","total_value":200853.48,"total_display":"200,853.48","total_whole":"200,853","shares_owned_after":15776.0,"shares_owned_after_display":"15,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-04","filed_date":"2019-04-04","scope":"insider"},{"id":8528689,"accession":"0001385508-19-000037","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001385508-19-000037","line_url":"/filing/0001385508-19-000037#line-4","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3791.0,"shares_display":"3,791","price_per_share":12.24,"price_display":"12.24","price_state":"stated","total_value":46401.84,"total_display":"46,401.84","total_whole":"46,402","shares_owned_after":10055.0,"shares_owned_after_display":"10,055","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-03","filed_date":"2019-04-04","scope":"insider"},{"id":8528683,"accession":"0001385508-19-000037","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-19-000037","line_url":"/filing/0001385508-19-000037#line-2","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":12.48,"price_display":"12.48","price_state":"stated","total_value":7488.0,"total_display":"7,488.00","total_whole":"7,488","shares_owned_after":13846.0,"shares_owned_after_display":"13,846","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-02","filed_date":"2019-04-04","scope":"insider"},{"id":8528677,"accession":"0001385508-19-000008","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001385508-19-000008","line_url":"/filing/0001385508-19-000008#line-6","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11407.0,"shares_display":"11,407","price_per_share":13.27,"price_display":"13.27","price_state":"stated","total_value":151370.89,"total_display":"151,370.89","total_whole":"151,371","shares_owned_after":8475.0,"shares_owned_after_display":"8,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-08","filed_date":"2019-01-08","scope":"insider"},{"id":8528675,"accession":"0001385508-19-000008","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001385508-19-000008","line_url":"/filing/0001385508-19-000008#line-5","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26759.0,"shares_display":"26,759","price_per_share":13.28,"price_display":"13.28","price_state":"stated","total_value":355359.52,"total_display":"355,359.52","total_whole":"355,360","shares_owned_after":19882.0,"shares_owned_after_display":"19,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-07","filed_date":"2019-01-08","scope":"insider"},{"id":8528664,"accession":"0001385508-19-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-19-000008","line_url":"/filing/0001385508-19-000008#line-2","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11834.0,"shares_display":"11,834","price_per_share":13.54,"price_display":"13.54","price_state":"stated","total_value":160232.36,"total_display":"160,232.36","total_whole":"160,232","shares_owned_after":13000.0,"shares_owned_after_display":"13,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-04","filed_date":"2019-01-08","scope":"insider"},{"id":6591039,"accession":"0001385508-18-000091","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-18-000091","line_url":"/filing/0001385508-18-000091#line-3","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6941.0,"shares_display":"6,941","price_per_share":17.04,"price_display":"17.04","price_state":"stated","total_value":118274.64,"total_display":"118,274.64","total_whole":"118,275","shares_owned_after":8475.0,"shares_owned_after_display":"8,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-09","filed_date":"2018-10-10","scope":"insider"},{"id":6591038,"accession":"0001385508-18-000091","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-18-000091","line_url":"/filing/0001385508-18-000091#line-2","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3059.0,"shares_display":"3,059","price_per_share":17.33,"price_display":"17.33","price_state":"stated","total_value":53012.47,"total_display":"53,012.47","total_whole":"53,012","shares_owned_after":15416.0,"shares_owned_after_display":"15,416","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-08","filed_date":"2018-10-10","scope":"insider"},{"id":6591036,"accession":"0001385508-18-000091","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001385508-18-000091","line_url":"/filing/0001385508-18-000091#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":847.0,"shares_display":"847","price_per_share":18.14,"price_display":"18.14","price_state":"stated","total_value":15364.58,"total_display":"15,364.58","total_whole":"15,365","shares_owned_after":18475.0,"shares_owned_after_display":"18,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-05","filed_date":"2018-10-10","scope":"insider"},{"id":6400805,"accession":"0001385508-18-000086","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001385508-18-000086","line_url":"/filing/0001385508-18-000086#line-4","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4006.0,"shares_display":"4,006","price_per_share":18.43,"price_display":"18.43","price_state":"stated","total_value":73830.58,"total_display":"73,830.58","total_whole":"73,831","shares_owned_after":19322.0,"shares_owned_after_display":"19,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-04","filed_date":"2018-10-04","scope":"insider"},{"id":6400803,"accession":"0001385508-18-000086","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001385508-18-000086","line_url":"/filing/0001385508-18-000086#line-3","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4300.0,"shares_display":"4,300","price_per_share":19.23,"price_display":"19.23","price_state":"stated","total_value":82689.0,"total_display":"82,689.00","total_whole":"82,689","shares_owned_after":23328.0,"shares_owned_after_display":"23,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-03","filed_date":"2018-10-04","scope":"insider"},{"id":6400801,"accession":"0001385508-18-000086","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001385508-18-000086","line_url":"/filing/0001385508-18-000086#line-2","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10144.0,"shares_display":"10,144","price_per_share":17.51,"price_display":"17.51","price_state":"stated","total_value":177621.44,"total_display":"177,621.44","total_whole":"177,621","shares_owned_after":27628.0,"shares_owned_after_display":"27,628","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-02","filed_date":"2018-10-04","scope":"insider"},{"id":4594594,"accession":"0001144204-17-002837","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-002837","line_url":"/filing/0001144204-17-002837#line-1","is_derivative":false,"issuer_cik":"0001385508","issuer_name":"OPIANT PHARMACEUTICALS, INC.","issuer_ticker":"OPNT","issuer_name_source":null,"issuer_url":"/issuer/0001385508","owner_cik":"0001656633","owner_name":"CRYSTAL ROGER","owner_display_name":"CRYSTAL ROGER","owner_url":"/insider/0001656633","role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3475.0,"shares_display":"3,475","price_per_share":6.99,"price_display":"6.99","price_state":"stated","total_value":24290.25,"total_display":"24,290.25","total_whole":"24,290","shares_owned_after":8475.0,"shares_owned_after_display":"8,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-17","filed_date":"2017-01-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001385508","name":"OPIANT PHARMACEUTICALS, INC.","url":"/issuer/0001385508","role":"Director, Officer (Chief Executive Officer), Ten percent owner","n_filings":13,"first_seen":"2017-01-19","last_seen":"2023-01-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001656633","retrieved_at":"2026-08-27T07:47:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}